|Articles|August 1, 2001
- Pharmaceutical Executive-08-01-2001
- Volume 0
- Issue 0
Generics: Streamline and Stimulate
Author(s)Kevin Gopal
Brussels-Lack of intellectual property protection is not causing the erosion of European pharma, reports the European Generics Association.
Advertisement
Articles in this issue
over 24 years ago
Decision Making at Digital Speedover 24 years ago
Mergers: Big Pharma Shrinks Someover 24 years ago
Grace Under Fireover 24 years ago
Get Ready to Merge or Divergeover 24 years ago
Pharma's Quantum Shuffleover 24 years ago
Science-Driven MarketingNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Bayer Shares Briefly Dip After Activist Investor Offloads Millions of Dollars in Company Stock
2
Pharmaceutical Executive Daily: FDA Issues Warning Letter to ImmunityBio
3
Pharma M&A Roundup: Merck to Acquire Terns Pharmaceuticals, Shionogi to Acquire 50% of Apnimed’s Ownership of Shionogi-Apnimed Sleep Science
4
FDA Sends Warning Letter to ImmunityBio for Misleading Claims in Advertisement
5